[1]
“Pharmacological Evaluation of CB2 Receptor Modulator in the Treatment of Neuropathic Pain”, JOC, vol. 24, no. 2s, pp. 867–885, Sep. 2025, doi: 10.64149/J.Carcinog.24.2s.867-885.